US FDA approves Verona Pharma’s inhaled COPD therapy
(Reuters) -The U.S. Food and Drug Administration has approved a treatment from Verona Pharma (NASDAQ: VRNA) for a chronic lung […]
US FDA approves Verona Pharma’s inhaled COPD therapy Read More »
NASDAQ: VRNA
